78995-98-9 Usage
Description
(3,3,4,4,4-D5)-(E/Z)-1-[4-(2-Chloroethoxy)phenyl]-1-[4-hydroxyphenyl]-2-phenyl-1-butene is a complex organic compound with a unique molecular structure. It is characterized by the presence of a butene backbone with two phenyl groups attached to it, as well as a chloroethoxyphenyl and a hydroxyphenyl group. (3,3,4,4,4-D5)-(E/Z)-1-[4-(2-Chloroethoxy)phenyl]-1-[4-hydroxyphenyl]-2-phenyl-1-butene also contains deuterium atoms, which are isotopes of hydrogen, at specific positions in the molecule. (3,3,4,4,4-D5)-(E/Z)-1-[4-(2-Chloroethoxy)phenyl]-1-[4-hydroxyphenyl]-2-phenyl-1-butene exists as a mixture of E/Z isomers, with the alpha isomer present in 10-20% of the total composition.
Uses
There is limited information provided on the specific applications of (3,3,4,4,4-D5)-(E/Z)-1-[4-(2-Chloroethoxy)phenyl]-1-[4-hydroxyphenyl]-2-phenyl-1-butene. However, given its unique molecular structure and the presence of functional groups, it is possible that the compound may have potential uses in various industries, such as pharmaceuticals, materials science, or chemical research. Further investigation and research would be required to determine the specific applications and benefits of this compound in different fields.
Check Digit Verification of cas no
The CAS Registry Mumber 78995-98-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,8,9,9 and 5 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 78995-98:
(7*7)+(6*8)+(5*9)+(4*9)+(3*5)+(2*9)+(1*8)=219
219 % 10 = 9
So 78995-98-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H16O/c1-8-5-4-6-10(2,3)9(8)7-11/h7H,4-6H2,1-3H3/i1D3,5D2
78995-98-9Relevant articles and documents
Retinoic acid analogues with ring modifications. Synthesis and pharmacological activity
Dawson,Hobbs,Chan,Chao
, p. 1214 - 1223 (2007/10/02)
Analogues of retinoic acid that have their major modifications in the 5,6 double bond and 4-methylene group regions of the β-cyclogeranylidene ring have been synthesized as potential agents for the treatment and prevention of epithelial cancer. These modi